Low-dose dobutamine gated-SPECT analysis of left ventricular segmental wall thickening in ischemic cardiomyopathy;Análisis del engrosamiento segmentario ventricular izquierdo con bajas dosis de dobutamina mediante gated-SPECT en la miocardiopatía isquémica

Revista Espanola de Cardiologia

Volumn 61, Issue 10, 2008, Pages 1061-1069

  Candell Riera, Jaume ^a   Romero Farina, Guillermo ^a   Milá, Marta ^a   Aguadé Bruix, Santiago ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Gated SPECT; Ischemic cardiomyopathy; Low dose dobutamine; Segmental thickening

Indexed keywords

DOBUTAMINE; TETROFOSMIN TC 99M;

ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEART VOLUME; HUMAN; ISCHEMIC CARDIOMYOPATHY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 55549110909     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13126046     Document Type: Article

References (26)

1. Bree D, Wollmuth JR, Cupps BP, Krock MD, Howells A, Rogers J, et al. Low-dose dobutamine tissue-tagged magnetic resonance imaging with 3-dimensional strain analysis allows assessment of myocardial viability in patients with ischemic cardiomyopathy. Circulation. 2006;114:I33-6.
2. Habis M, Capderou A, Ghostine S, Daoud B, Caussin C, Riou JY, et al. Acute myocardial infarction early viability assessment by 64-slice computed tomography immediately after coronary angiography: comparison with low-dose dobutamine echocardiography. J Am Coll Cardiol. 2007;49:1178-85.
3. Sawada SG, Safadi A, Gaitonde RS, Tung N, Mahenthiran J, Gill W, et al. Stress-induced wall motion abnormalities with low-dose dobutamine infusión indicate the presence of severe disease and vulnerable myocardium. Echocardiography. 2007;24:739-44.
4. Everaert H, Vanhove Ch, Franken Ph. Assessment of perfusion, function, and myocardialmetabolism after infarction with a combination of low-dose dobutamine tetrofosmin gated SPECT perfusion scintigraphy and BMIPP SPECT imaging. J Nucl Cardiol. 2000;7:296-36.
5. Leoncini M, Marcucci G, Sciagrá R, Mondanelli D, Traini AM, Magni M, et al. Comparison of baseline and low-dose dobutamine technetium-99m sestamibi scintigraphy with low-dose dobutamine echocardiography for predicting functional recovery after revascularization. Am J Cardiol. 2000;86:153-7.
6. Ruiz-Salmeron RJ, Ponce de León E, López A, Romeo D, Del Campo V, Nandayapa R, et al. Capacidad del protocolo de gated-SPECT reposo/dobutamina para predecir la recuperación contráctil posrevascularización de áreas miocárdicas disinérgicas. Rev Esp Cardiol. 2000;53:1052-62.
7. Everaert H, Vanhove CH, Franken R. Low-dose dobutamine gated single-photon emission tomography: comparison with stress echocardiography. Eur J Nucl Med. 2000;27:413-8.
8. Leoncini M, Marcucci G, Sciagrá R, Frascarelli F, Traini AM, Mondanelli D, et al. Nitrate-enhanced gated technetium 99m sestamibi SPECT for evaluating regional wall motion at baseline and during low-dose dobutamine infusion in patients with chronic coronary artery disease and left ventricular dysfunction: comparison with two-dimensional echocardiography. J Nucl Cardiol. 2000;7:426-31.
9. Yamagishi H, Akioka K, Hirata K, Sakanoue Y, Toda I, Yoshiyama M, et al. Dobutamine stress electrocardiographygated Tc-99m tetrofosmin SPECT for detection of viable but dysfunctional myocardium. J Nucl Cardiol. 2001;8:58-66.
10. Yoshinaga K, Morita K, Yamada S, Komuro K, Katoh C, Ito Y, et al. Low-dose dobutamine electrocardiograph-gated myocardial SPECT for identifying viable myocardium: comparison with dobutamine stress echocardiography and PET. J Nucl Med. 2001;42:838-44.
11. Leoncini M, Marcucci G, Sciagrá R, Frascarelli F, Simonetti I, Bini L, et al. Prediction of functional recovery in patients with chronic coronary artery disease and left ventricular dysfunction combining the evaluation of myocardial perfusion and of contractile reserve using nitrate-enhanced technetium-99m sestamibi gated single-photon emission computed tomography and dobutamine stress. Am J Cardiol. 2001;87:1346-50.
12. Yoshinaga K, Katoh C, Noriyasu K, Yamada S, Ito Y, Kuge Y, et al. Low-dose dobutamine stress gated SPET for identification of viable myocardium: comparison with stress-rest perfusion SPET and PET. Eur J Nucl Med Mol Imaging. 2002;29:882-90.
13. Leoncini M, Sciagrá R, Maioli M, Bellandi F, Marcucci G, Sestini S, et al. Usefulness of dobutamine Tc-99m sestamibigated single-photon emission computed tomography for prediction of left ventricular ejection fraction outcome after coronary revascularization for ischemic cardiomyopathy. Am J Cardiol. 2002;89:817-81.
14. Leoncini M, Sciagrá R, Bellandi F, Maioli M, Sestini S, Marcucci G, et al. Low-dose dobutamine nitrate-enhanced technetium 99m sestamibi gated SPECT versus low-dose dobutamine echocardiography for detecting reversible dysfunction in ischemic cardiomyopathy. J Nucl Cardiol. 2002;9:402-6.
15. Heiba ShI, Abdel-Dayem HM, Gould R, Bernaski E, Marlote M, El-Zeftaway, et al. Value of low-dose dobutamine addition to routine dual isotope gated-SPECT myocardial imaging in patients with healed myocardial infarction or abnormal wall thickening by echocardiogram. Am J Cardiol. 2004;93:300-6.
16. Schinkel AF, Poldermans D, Elhendy A, Bax JJ. Prognostic role of dobutamine stress echocardiography in myocardial viability. Curr Opin Cardiol. 2006;21:443-9.
17. Rizzello V, Poldermans D, Schinkel AF, Biagini E, Boersma E, Elhendy A, et al. Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation. Heart. 2006;92:239-44.
18. Hanekom L, Jenkins C, Jeffries L, Case C, Mundy J, Hawley C, et al. Incremental value of strain rate analysis as an adjunct to wall-motion scoring for assessment of myocardial viability by dobutamine echocardiography: a follow-up study after revascularization. Circulation. 2005;112:3892-900.
19. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J. 2007;28:2525-38.
20. Castell-Conesa J, Aguadé-Bruix S, García-Burillo A, González JM, Canela T, Oller G, et al. Reproducibilidad de la gated-SPECT de perfusión miocárdica en la valoración de la función ventricular y su comparación con la ventriculografí a isotópica. Rev Esp Cardiol. 2004;57:931-8.
21. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 1995;36:2138-47.
22. Schinkel AF, Bax JJ, Van Domburg R, Elhendy A, Valkema R, Vourvouri EC, et al. Dobutamine-induced contractile reserve in stunned, hibernating, and scarred myocardium in patients with ischemic cardiomyopathy. J Nucl Med. 2003;44:127-33.
23. Everaert H, Vanhove CH, Franken R. Effects of low-dose dobutamine on left ventricular function in normal subjects as assessed by gated single-photon emission tomography myocardial perfusion studies. Eur J Nucl Med. 1999;26:1298-303.
24. Sanchis J, Bodí V, Berenguer A, Insa L, Mainar L, Valls A, et al. Determinantes de la RC en la zona del infarto. Estudio cuantitativo mediante ventriculografía de contraste con dobutamina. Rev Esp Cardiol. 2000;53:617-24.
25. Bove CM, DiMaria JM, Voros S, Conaway MR, Kramer CM. Dobutamine response and myocardial infarct transmurality: functional improvement after coronary artery bypass grafting - Initial experience. Radiology. 2006;240:835-41.
26. Romero-Farina G, Candell-Riera J, Aguadé-Bruix S, Castell-Conesa J, De León G, Igual A, et al. Variables predictoras de mejoría de la función sistólica ventricular izquierda después de la cirugía de revascularización coronaria en pacientes con miocardiopatía isquémica. Rev Esp Cardiol. 2007;60:943-51.